Jupiter Neurosciences Inc
JUNS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.48M
Close$
$-3.33
209.3% downside
Current Fair Value
209.3% downsideOvervalued by 209.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.48 Million |
|---|---|
| Enterprise Value | $1.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.75 |
| Beta | 1.79 |
| Outstanding Shares | 557,567 |
Return
| Return on Equity | 2513.74% |
|---|---|
| Return on Assets | -247.39% |
| Return on Invested Capital | 5907.69% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | -16.59 |
| Price to Sales | - |
| Price to Book Ratio | -3.05 |
| Enterprise Value to Revenue | 26.38 |
| Enterprise Value to EBIT | -0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | -4.78 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-3.75
Average shareholder expectationRevenue Estimate
$400,000
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-3.75
Average shareholder expectationRevenue Estimate
$602,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.00%▼ 2.40% |
|---|---|
| Total Invested | $826,873▲ 15.46% |
| Investors Holding | 13▲ 3.00% |
ESG Score
No data